Evergreen Theragnostics Stock

Evergreen Theragnostics was established in 2019 as a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). The team focuses on theragnostic radiopharmaceutical commercialization, manufacturing process development, and regulatory affairs management. Evergreen partners with companies on radiopharmaceutical development, manufacturing, and commercialization needs.